Product approval information is indicated for children and adults with hemophilia B (congenital Factor IX deficiency) for 1) On-demand control and prevention of bleeding episodes; 2) Perioperative management of bleeding; 3) Routine prophylaxis to prevent or reduce the frequency of bleeding episodes.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2oyFIU5
No comments:
Post a Comment